Measuring a blood protein to detect lupus-related kidney disease
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at a blood test for a protein called RNASE1 to see if it can help identify kidney problems in people with lupus. It may help doctors diagnose and monitor lupus nephritis more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with systemic lupus erythematosus (SLE)
- You either have lupus nephritis or you do not have lupus nephritis (researchers are comparing both groups)
- You do not have other autoimmune diseases, active infections, or cancer
- You are not pregnant or breastfeeding
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.
This study looks at two blood tests (albumin/globulin ratio and platelet/albumin ratio) to see if they can help understand lupus nephritis, a serious kidney problem caused by lupus. If you have lupus nephritis, your participation may help improve how doctors monitor and manage this condition.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study uses a simple blood test to estimate the risk of heart and blood vessel problems in people with lupus nephritis. It aims to find early signs of heart disease before symptoms appear.
Hear when a new System Lupus Erythematosus(SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.